This weeks interview is with Covestor member Ward Kadel, aka drxeno. Ward works as a Senior Research Analyst at Genentech, Inc. where he develops pharmacodynamic assays for oncology drugs that are about to enter, or are in, early clinical trials. Ward holds a mixture of ultra-long ETF postions to balance […]